Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies

NCT03522142 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT03522142
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03522142 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1a/1b Study Exploring the Safety and Tolerability of INCB081776 in Participants With Advanced Malignancies
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Terminated
Start date
August 27, 2018
Completion date
September 10, 2025
Enrollment
83 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors